BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11470488)

  • 1. Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers.
    Knobloch TJ; Lynch MA; Song H; DeGroff VL; Casto BC; Adams EM; Alam KY; Lang JC; Schuller DE; Weghorst CM
    Mutat Res; 2001 Aug; 479(1-2):131-9. PubMed ID: 11470488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck.
    Wang D; Song H; Evans JA; Lang JC; Schuller DE; Weghorst CM
    Carcinogenesis; 1997 Nov; 18(11):2285-90. PubMed ID: 9395234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the transforming growth factor beta receptor type I gene in primary non-small cell lung cancer.
    Zhang HT; Fei QY; Chen F; Qi QY; Zou W; Wang JC; Zhang RM; Tao SH; Chen XF; Luo ZW
    Lung Cancer; 2003 Jun; 40(3):281-7. PubMed ID: 12781426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of the transforming growth factor-beta type II receptor gene is a rare event in human sporadic gastric carcinomas.
    Shitara Y; Yokozaki H; Yasui W; Takenoshita S; Nagamachi Y; Tahara E
    Int J Oncol; 1998 May; 12(5):1061-5. PubMed ID: 9538129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genetic alterations in the TGFbeta type II receptor gene promoter.
    Seijo ER; Song H; Lynch MA; Jennings R; Qong X; Lazaridis E; Muro-Cacho C; Weghorst CM; Muñoz-Antonia T
    Mutat Res; 2001 Nov; 483(1-2):19-26. PubMed ID: 11600128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma.
    Schiemann WP; Pfeifer WM; Levi E; Kadin ME; Lodish HF
    Blood; 1999 Oct; 94(8):2854-61. PubMed ID: 10515889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
    Qiu W; Schönleben F; Li X; Su GH
    Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic acquisition and signaling of TGFBR1*6A in cancer.
    Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
    JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.
    Chen T; Triplett J; Dehner B; Hurst B; Colligan B; Pemberton J; Graff JR; Carter JH
    Cancer Res; 2001 Jun; 61(12):4679-82. PubMed ID: 11406536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder.
    Chen T; Jackson C; Costello B; Singer N; Colligan B; Douglass L; Pemberton J; Deddens J; Graff JR; Carter JH
    Int J Cancer; 2004 Nov; 112(3):420-5. PubMed ID: 15382067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TbetaR-I(6A) is a candidate tumor susceptibility allele.
    Pasche B; Kolachana P; Nafa K; Satagopan J; Chen YG; Lo RS; Brener D; Yang D; Kirstein L; Oddoux C; Ostrer H; Vineis P; Varesco L; Jhanwar S; Luzzatto L; Massagué J; Offit K
    Cancer Res; 1999 Nov; 59(22):5678-82. PubMed ID: 10582683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma.
    Lynch MA; Nakashima R; Song H; DeGroff VL; Wang D; Enomoto T; Weghorst CM
    Cancer Res; 1998 Oct; 58(19):4227-32. PubMed ID: 9766642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
    Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
    Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
    Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
    Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
    Park B; Jang JS; Park K
    Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.
    Chen T; Yan W; Wells RG; Rimm DL; McNiff J; Leffell D; Reiss M
    Int J Cancer; 2001 Sep; 93(5):653-61. PubMed ID: 11477574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
    Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta receptors in verrucous and squamous cell carcinoma.
    Anderson M; Muro-Cacho C; Cordero J; Livingston S; Muñoz-Antonia T
    Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):849-54. PubMed ID: 10448730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.